Jax Thomas W, Peters Ansgar J, Plehn Gunnar, Schoebel Frank-Chris
Medizinische Klinik und Poliklinik B, Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universität, Duesseldorf, Germany.
Cardiovasc Diabetol. 2009 Sep 7;8:48. doi: 10.1186/1475-2840-8-48.
Thrombosis is regarded to be a key factor in the development of acute coronary syndromes in patients with coronary artery disease (CAD). We hypothesize, that hemostatic and rheological risk factors may be of major relevance for the incidence and the risk stratification of these patients.
In 243 patients with coronary artery disease and stable angina pectoris parameters of metabolism, hemostasis, blood rheology and endogenous fibrinolysis were assessed. Patients were prospectively followed for 2 years in respect to elective revascularizations and acute coronary syndromes.
During follow-up 88 patients presented with cardiac events, 22 of those were admitted to the hospital because of acute events, 5 Patients were excluded due to non- cardiac death. Patients with clinical events were found to be more frequently diabetic and presented with a more progressed coronary atherosclerosis. Even though patients with diabetes mellitus demonstrated a comparable level of multivessel disease (71% vs. 70%) the rate of elective revascularization was higher (41% vs. 28%, p < 0.05). The results were also unfavorable for the incidence of acute cardiovascular events (18% vs. 8%, p < 0.01). In comparison to non-diabetic patients diabetics demonstrated significantly elevated levels of fibrinogen (352 +/- 76 vs. 312 +/- 64 mg/dl, p < 0.01), plasma viscosity (1.38 +/- 0.23 vs. 1.31 +/- 0.16 mPas, p < 0.01), red blood cell aggregation (13.2 +/- 2.5 vs. 12.1 +/- 3.1 E, p < 0.05) and plasmin-activator-inhibitor (6.11 +/- 3.4 vs. 4.7 +/- 2.7 U/l, p < 0.05).
Pathological alterations of fibrinogen, blood rheology and plasminogen-activator-inhibitor as indicators of a procoagulant state are of major relevance for the short-term incidence of cardiac events, especially in patients with diabetes mellitus type 2, and may be used to stratify patients to specific therapies.
血栓形成被认为是冠状动脉疾病(CAD)患者急性冠状动脉综合征发生发展的关键因素。我们推测,止血和血液流变学危险因素可能与这些患者的发病率及风险分层密切相关。
对243例患有冠状动脉疾病且有稳定型心绞痛的患者进行代谢、止血、血液流变学及内源性纤维蛋白溶解参数评估。对患者进行前瞻性随访2年,观察择期血运重建和急性冠状动脉综合征情况。
随访期间,88例患者出现心脏事件,其中22例因急性事件入院,5例因非心脏死亡被排除。发现发生临床事件的患者糖尿病患病率更高,冠状动脉粥样硬化程度更严重。尽管糖尿病患者的多支血管病变水平相当(71%对70%),但择期血运重建率更高(41%对28%,p<0.05)。这一结果对急性心血管事件的发生率也不利(18%对8%,p<0.01)。与非糖尿病患者相比,糖尿病患者的纤维蛋白原水平显著升高(352±76对312±64mg/dl,p<0.01)、血浆黏度升高(1.38±0.23对1.31±0.16mPas,p<0.01)、红细胞聚集性升高(13.2±2.5对12.1±3.1E,p<0.05)以及纤溶酶激活物抑制剂升高(6.11±3.4对4.7±2.7U/l,p<0.05)。
作为促凝状态指标的纤维蛋白原、血液流变学及纤溶酶原激活物抑制剂的病理改变与心脏事件的短期发生率密切相关,尤其是在2型糖尿病患者中,可用于将患者分层以进行特定治疗。